Correlation Between Capital Income and Acerus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Capital Income and Acerus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capital Income and Acerus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capital Income Builder and Acerus Pharmaceuticals, you can compare the effects of market volatilities on Capital Income and Acerus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capital Income with a short position of Acerus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capital Income and Acerus Pharmaceuticals.
Diversification Opportunities for Capital Income and Acerus Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Capital and Acerus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Capital Income Builder and Acerus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acerus Pharmaceuticals and Capital Income is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capital Income Builder are associated (or correlated) with Acerus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acerus Pharmaceuticals has no effect on the direction of Capital Income i.e., Capital Income and Acerus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Capital Income and Acerus Pharmaceuticals
If you would invest 6,375 in Capital Income Builder on November 3, 2024 and sell it today you would earn a total of 724.00 from holding Capital Income Builder or generate 11.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Capital Income Builder vs. Acerus Pharmaceuticals
Performance |
| Timeline |
| Capital Income Builder |
| Acerus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Capital Income and Acerus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Capital Income and Acerus Pharmaceuticals
The main advantage of trading using opposite Capital Income and Acerus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capital Income position performs unexpectedly, Acerus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acerus Pharmaceuticals will offset losses from the drop in Acerus Pharmaceuticals' long position.| Capital Income vs. Dws Global Macro | Capital Income vs. Rbb Fund | Capital Income vs. Kinetics Global Fund | Capital Income vs. Ms Global Fixed |
| Acerus Pharmaceuticals vs. Weibo Corp | Acerus Pharmaceuticals vs. Mills Music Trust | Acerus Pharmaceuticals vs. Radcom | Acerus Pharmaceuticals vs. Tandem Diabetes Care |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |